• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Promise Bio Secures $8.3M for Auto-Immune Precision Medicine Platform

by Syed Hamza Sohail 12/16/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  Promise Bio, a startup transforming immune-mediated disease treatment with advanced precision medicine solutions, today announced its emergence from stealth with an $8.3 million seed investment.

– This funding will accelerate the development of Promise Bio’s computational platform, which uses epiproteomics and artificial intelligence to predict patient treatment responses and support drug research and development.

Revolutionizing Immune-Mediated Disease Management through Epiproteomics and AI

Promise Bio is a trailblazer in precision medicine, advancing the management of immune-mediated diseases with an innovative focus on epiproteomics and artificial intelligence (AI). Leveraging groundbreaking research from the Weizmann Institute of Science, the company’s proprietary technology enables large-scale profiling of post-translational modifications (PTMs) in proteins. This platform identifies disease mechanisms, customizes therapies, and uncovers novel drug targets with unparalleled precision.

At the core of Promise Bio’s success is its proprietary PROMISE (Protein Modification Integrated Search Engine) platform, developed by Co-Founder & CTO Dr. Assaf Kacen. This cutting-edge system, based on foundational research conducted in Prof. Yifat Merbl’s lab at the Weizmann Institute and published in Nature Biotechnology in 2023, allows high-throughput profiling of dozens of PTMs using mass spectrometry. The platform eliminates the need for customized chemical enrichment or additional lab procedures, significantly streamlining the analysis of PTMs and accelerating biomedical discovery.

Strategic partnerships with two leading biopharmaceutical companies enhance Promise Bio’s capacity to integrate its technology into global drug development pipelines. These alliances provide:

  • Financial support, ensuring sustained innovation.
  • Industry expertise, enabling effective translation of research into clinical applications.
  • Access to global networks, fostering collaboration and expanding the reach of precision medicine solutions.

By building the world’s largest PTM database, Promise Bio is creating an indispensable resource for medical breakthroughs while addressing pressing clinical challenges in immune-mediated diseases.

Addressing the unmet need for precision treatments, Promise Bio targets the current inefficiencies in autoimmune disease therapies, where only 30–40% of patients achieve significant remission. The company emphasizes data-driven approaches to eliminate the trial-and-error treatment paradigm. Its PROMISE platform focuses not only on protein levels but also on the modifications proteins undergo after formation, delivering actionable insights for tailored interventions.

“Proteins are the building blocks of the human body, and understanding their post-formation changes is key to solving the challenges in immune-mediated diseases,” explained Ronel Veksler, Co-Founder & CEO. With this vision, Promise Bio is poised to transform the future of precision medicine.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |